Shengfa Su
Impact in
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
- Oncology top 10%
- Lung Cancer Research Studies
Papers in ⓘ
-
- Lung Cancer Diagnosis and Treatment 18
- Lung Cancer Treatments and Mutations 18
- Pleural and Pulmonary Diseases 3
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Oncology 13
- Lung Cancer Research Studies 10
- Co-authors
- Tai‐Xiang Lu (2 shared papers)Chong Zhao (2 shared papers)Fei Han (2 shared papers)Weiwei Xiao (2 shared papers)Chunyan Chen (1 shared paper)Xueming Sun (1 shared paper)Chengguang Lin (1 shared paper)Xiaowu Deng (1 shared paper)
- Journals
- BMC Cancer (4 papers)Frontiers in Oncology (4 papers)Cancer Medicine (3 papers)Radiotherapy and Oncology (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)
- Partner nations
- China
In The Last Decade
Shengfa Su
26 papers receiving 585 citations
Hit Papers
Peers
Comparison fields: 5 of 59
- Otorhinolaryngology 358
- Oncology 251
- Pulmonary and Respiratory Medicine 247
- Cancer Research 74
- Surgery 216
Countries citing papers authored by Shengfa Su
This map shows the geographic impact of Shengfa Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengfa Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengfa Su more than expected).
Fields of papers citing papers by Shengfa Su
This network shows the impact of papers produced by Shengfa Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengfa Su. The network helps show where Shengfa Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Shengfa Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities Hit paper breakdown → | 2013 | 433 |
| 2 | 2015 | 33 | |
| 3 | 2013 | 16 | |
| 4 | 2014 | 15 | |
| 5 | 2014 | 13 | |
| 6 | 2022 | 13 | |
| 7 | 2024 | 7 | |
| 8 | 2014 | 6 | |
| 9 | [Expression of ASPP gene family and its relationship with survival of patients with non-small cell lung cancer]. | 2014 | 6 |
| 10 | Randomized phase II study of pemetrexed-cisplatin or docetaxel-cisplatin plus thoracic intensity-modulated radiation therapy in patients with stage IV lung adenocarcinoma. | 2019 | 6 |
| 11 | 2021 | 5 | |
| 12 | 2010 | 4 | |
| 13 | 2020 | 4 | |
| 14 | 2022 | 4 | |
| 15 | 2022 | 3 | |
| 16 | 2022 | 3 | |
| 17 | 2023 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2021 | 2 | |
| 20 | 2023 | 2 |
About Shengfa Su
Shengfa Su is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 33 papers that have together received 588 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (18 papers), Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (10 papers), Pleural and Pulmonary Diseases (3 papers), Head and Neck Cancer Studies (3 papers), Advanced Radiotherapy Techniques (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). The work is most often cited by research in Otorhinolaryngology (358 citations), Oncology (251 citations), Pulmonary and Respiratory Medicine (247 citations), Cancer Research (74 citations) and Surgery (216 citations). Shengfa Su has collaborated with scholars based in China. Frequent co-authors include Tai‐Xiang Lu, Chong Zhao, Fei Han, Weiwei Xiao, Chunyan Chen, Xueming Sun, Chengguang Lin, Xiaowu Deng, Shaomin Huang and Weiwei Ouyang. Their work appears in journals such as BMC Cancer, Frontiers in Oncology, Cancer Medicine, Radiotherapy and Oncology and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.